Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Amylin is a member of the calcitonin family of hormones cosecreted with insulin by pancreatic β cells. Cell culture assays suggest that amylin could affect bone formation and bone resorption, this latter function after its binding to the calcitonin receptor (CALCR). Here we show that Amylin inactivation leads to a low bone mass due to an increase in bone resorption, whereas bone formation is unaffected. In vitro, amylin inhibits fusion of mononucleated osteoclast precursors into multinucleated osteoclasts in an ERK1/2-dependent manner. Although Amylin +/− mice like Amylin-deficient mice display a low bone mass phenotype and increased bone resorption, Calcr +/− mice display a high bone mass due to an increase in bone formation. Moreover, compound heterozygote mice for Calcr and Amylin inactivation displayed bone abnormalities observed in both Calcr +/− and Amylin +/− mice, thereby ruling out that amylin uses CALCR to inhibit osteoclastogenesis in vivo. Thus, amylin is a physiological regulator of bone resorption that acts through an unidentified receptor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A later study found that the activity of amylin to inhibit cell fusion required the activation of the extracellular signal-regulated protein kinase 1/2 (ERK1/2) in osteoclast precursors (58).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [58]
The cited source says what the claim attributes to it.
In the citing paper
“Amylin deficiency had no effect on the regulation of food intake, body weight, or glucose metabolism in this experimental model.”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [58]
The cited source says what the claim attributes to it.
In the citing paper
“The amylin KO mice had an increased number of osteoclasts and an increase in degradation products of collagen in the urine, suggesting that the osteoporotic phenotype was a result of accelerated bone resorption (58).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [58]
The cited source says what the claim attributes to it.
In the citing paper
“Similar to the phenotype described for the Calca-deficient mice (97), Calcr ϩ/Ϫ mice had high bone mass caused by increased bone formation without changes in bone resorption (58).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [58]
The cited source says what the claim attributes to it.
In the citing paper
“At the age of 24 wk, both male and female amylin KO mice were osteoporotic with vertebral bone volume over tissue volume (BV/TV) ~50% lower than that of WT and trabecular and cortical bone thickness reduced.”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [58]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoclast differentiation and activation
Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670 · cited 2×
“…studies have identified transcription factors, growth factors and their receptors, hormones and intracellular signaling molecules that affect one or the other arm of bone remodeling at the level of cell differentiation, proliferation, or function (Boyle et al., 2003; Teitelbaum and Ross, 2003).”
BackgroundParfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,016 · cited 1×
“This was surprising as the calcitonin receptor (CALCR) is expressed on osteoclasts but not on osteoblasts ( Nicholson et al., 1986; Lee et al., 1995).”
BackgroundBone Histomorphometry : Standardization of Nomenclature, Symbols, and Units
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · Cited by 3,258
Genetic regulation of osteoclast development and function
Teitelbaum, S. L., & Ross, F. P. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1122 · Cited by 1,701 · cited 1×
“These latter studies have identified transcription factors, growth factors and their receptors, hormones and intracellular signaling molecules that affect one or the other arm of bone remodeling at the level of cell differentiation, proliferation, or function (Boyle et al., 2003; Teitelbaum and Ross, 2003).”
BackgroundEffects of Diabetes Mellitus on Bone Mass in Juvenile and Adult-Onset Diabetes
Levin, M. E., Boisseau, V. C., & Avioli, L. V. (1976) · New England Journal of Medicine · doi:10.1056/nejm197601292940502 · Cited by 519 · cited 1×
“Indeed, the predominant expression of amylin in pancreatic cells support the hypothesis that the low bone mass phenotype observed in Type I diabetes patients (Levin et al., 1976) may be secondary, at least in part, to the absence of amylin secretion in these patients.”
BackgroundChristopoulos, G., Perry, K. J., Morfis, M., Tilakaratne, N., Gao, Y., Fraser, N. J., Main, M. J., Foord, S. M., & Sexton, P. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.235 · Cited by 486 · cited 2×
“, 1999, 2001); that amylin is able to bind in vitro to CALCR has raised the hypothesis that it may be a physiological ligand of CALCR on osteoclasts (Christopoulos et al., 1999).”
BackgroundNicholson, G. C., Moseley, J. M., Sexton, P. M., Mendelsohn, F. A., & Martin, T. J. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112584 · Cited by 454 · cited 2×
“This was surprising as the calcitonin receptor (CALCR) is expressed on osteoclasts but not on osteoblasts (Nicholson et al., 1986; Lee et al., 1995).”
BackgroundEvidence of Cosecretion of Islet Amyloid Polypeptide and Insulin by β-Cells
Kahn, S. E., D'Alessio, D. A., Schwartz, M. W., Fujimoto, W. Y., Ensinck, J. W., Taborsky, G. J., & Porte, D. (1990) · Diabetes · doi:10.2337/diab.39.5.634 · Cited by 454 · cited 2×
“Amylin, the focus of this paper, was identified as a protein present in pancreatic cells that is cosecreted with insulin after food ingestion (Westermark et al., 1987; Kahn et al., 1990).”
BackgroundRoh, J., Chang, C. L., Bhalla, A., Klein, C., & Hsu, S. Y. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305332200 · Cited by 443
Amylin, Calcitonin Gene-Related Peptide, Calcitonin, and Adrenomedullin: A Peptide Superfamily
Wimalawansa, S. J. (1997) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v11.i2-3.40 · Cited by 424 · cited 2×
“Calcitonin is the founding member of a small family of polypeptide hormones that comprises of CGRP, adrenomedullin, intermedin, CALCR stimulating hormone, and amylin or islet amyloid polypeptide (Wimalawansa, 1997; Katafuchi et al., 2003; Roh et al., 2003).”
Background
Research works printed but not linked: 4
- 1998, Am. J. Physiol., 275, E694
- 1995, Endocrinology., 136, 4572, 10.1210/endo.136.10.7664679 · doi:10.1210/endo.136.10.7664679 · Paper page
- 1992, Endocrinology., 131, 1497, 10.1210/endo.131.3.1324163 · doi:10.1210/endo.131.3.1324163 · Paper page
- 1987, Am. J. Pathol., 127, 414
Cited by
Items 101–200 of 210
Montalcini, T., Gallotti, P., Coppola, A., Zambianchi, V., Fodaro, M., Galliera, E., Marazzi, M. G., Romeo, S., Giannini, S., Romanelli, M. M. C., et al. (2015) · Osteoporosis International · doi:10.1007/s00198-015-3040-2 · Cited by 26
Effects of Amylin Deficiency on Trabecular Bone in Young Mice Are Sex-Dependent
Davey, R. A., Moore, A. J., Chiu, M. W. S., Notini, A. J., Morris, H. A., & Zajac, J. D. (2006) · Calcified Tissue International · doi:10.1007/s00223-005-0286-2 · Cited by 25
“We previously demonstrated, however, that bone resorption as assessed by urine deoxypyridinoline excretion is increased in Amylin-deficient mice from 8 weeks of age, with osteoclast number increased at 12 weeks of age [1].”
BackgroundResultSelf-citationViney, T. J., Schmidt, T. W., Gierasch, W. W., Sattar, A. W., Yaggie, R. E., Kuburas, A., Quinn, J. P., Coulson, J. M., & Russo, A. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406659200 · Cited by 24
PRABHAKARAN, K., Harris, E. B., & Kirchheimer, W. F. (1972) · PubMed · Cited by 23
Decline in calcitonin receptor expression in osteocytes with age
Gooi, J. H., Chia, L. Y., Walsh, N. C., Karsdal, M. A., Quinn, J. M. W., Martin, T. J., & Sims, N. A. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0524 · Cited by 22
“…young CTR and CT/calcitonin gene-related peptide (CGRP)-deficient mice have been reported to exhibit increased bone formation (Hoff et al. 2002, Dacquin et al. 2004), and sCT treatment stimulates levels of sclerostin, a bone formation inhibitor, in both calvariae and long bones of young mice…”
BackgroundCalcitonin substitution in calcitonin deficiency reduces particle-induced osteolysis
Kauther, M. D., Bachmann, H. S., Neuerburg, L., Broecker-Preuss, M., Hilken, G., Grabellus, F., Koehler, G., von Knoch, M., & Wedemeyer, C. (2011) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-12-186 · Cited by 22
“observed increased bone formation with no consequences for bone resorption [37].”
BackgroundWhat does genetics tell us about imprinting and the placenta connection?
Varmuza, S., & Miri, K. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1714-0 · Cited by 22
A small RNA makes a Bic difference
Moffett, H. F., & Novina, C. D. (2007) · Genome biology · doi:10.1186/gb-2007-8-7-221 · Cited by 22
“Deletion of portions of the CalcR gene may have affected miR489 expression and the deletion of portions of the αMHC gene may have affected miR208 expression by disrupting miRNA processing from their host protein coding transcripts.”
BackgroundCalcitonin Physiology, Saved by a Lysophospholipid
Martin, T. J., & Sims, N. A. (2015) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2449 · Cited by 21
“Shortly after this work, young Calcrþ/ mice were reported to exhibit a bone phenotype virtually indistinguishable from that of the ligand null mice: high bone mass and increased bone formation by histomorphometry.((16)) Study of the hemizygotes was necessary because germline ablation of the calcitonin receptor (CTR) r…”
BackgroundLi, Q., Duan, Z., Sun, C., Zheng, J., Xu, G., & Yang, N. (2021) · BMC Genomics · doi:10.1186/s12864-021-08103-1 · Cited by 23
Skeletal morphofunctional considerations and the pituitary-thyroid axis
Iqbal, J. Z. (2009) · Frontiers in Bioscience-Elite · doi:10.2741/e9 · Cited by 20
“However, it is unlikely that amylin interacts with the CTR as compound amylin/CTR mice have a dual phenotype (93).”
BackgroundNakamura, M., Morimoto, S., Yang, Q., Hisamatsu, T., Hanai, N., Nakamura, Y., Mori, I., & Kakudo, K. (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01652 · Cited by 23
“It has been reported that bone abnormalities were observed in both CTR +/ and AMY +/ mice, thereby ruling out the possibility that AMY uses CTR to inhibit osteoclastogenesis in vivo (Dacquin et al. 2004).”
BackgroundChapter 5 Imprinting and Extraembryonic Tissues—Mom Takes Control
Miri, K., & Varmuza, S. (2009) · International review of cytology · doi:10.1016/s1937-6448(09)76005-8 · Cited by 22
The effects of anti‐obesity medications on bone metabolism: A critical appraisal
Anastasilakis, A. D., Paccou, J., Palermo, A., & Pοlyzos, S. A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16541 · Cited by 21
“93 However, pramlintide, another amylin analogue used as an adjuvant to insulin in T1DM patients, had no effect on LS BMD and BTMs over 1 year of treatment.”
Regulation of Sclerostin Expression by Paracrine and Endocrine Factors
Sims, N. A., & Chia, L. Y. (2011) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-011-9121-7 · Cited by 20
“Furthermore, mice haploinsufficient for CTR also exhibited increased bone mass and bone formation [62].”
BackgroundAmylin exerts osteogenic actions with different efficacy depending on the diabetic status
Gutiérrez-Rojas, I., Lozano, D., Nuche‐Berenguer, B., Moreno, P., Acitores, A., Ramos-Álvarez, I., Rovira, A., Novials, A., Martín-Crespo, E., Villanueva‐Peñacarrillo, M. L., et al. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.11.013 · Cited by 18
“…interact with calcitonin receptors in cells of the osteoclastic lineage to inhibit 1,25-dihydroxycholecalciferolinduced osteoclastogenesis in mouse bone marrow cultures (Cornish et al., 2001); yet amylin has anti-resorptive effects in mice with deficiency for these receptors (Dacquin et al., 2004).”
Gong, G., Du, W., Xu, J., Huang, X., & Yin, G. (2018) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2018.08.012 · Cited by 16
Effect of Dipeptidyl Peptidase-4 Inhibitors on the Risk of Bone Fractures in a Korean Population
Ustulin, M., Park, S. Y., Choi, H., Chon, S., Woo, J., & Rhee, S. Y. (2019) · Journal of Korean Medical Science · doi:10.3346/jkms.2019.34.e224 · Cited by 17
Wookey, P. J., Turner, K. N., & Furness, J. B. (2012) · Cell and Tissue Research · doi:10.1007/s00441-011-1303-6 · Cited by 15
“Further evidence for an important early role of calcitonin/CTR is the death of CTR-/- mice in utero (Dacquin et al. 2004).”
BackgroundDifferential effects of Calca-derived peptides in male mice with diet-induced obesity
Bartelt, A., Jeschke, A., Müller, B., Gaziano, I., Morales, M., Yorgan, T. A., Heckt, T., Heine, M., Gagel, R. F., Emeson, R. B., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180547 · Cited by 16
Energy metabolism and the skeleton: Reciprocal interplay
Amelio, P. (2012) · World Journal of Orthopedics · doi:10.5312/wjo.v3.i11.190 · Cited by 18
Identification of key immune genes of osteoporosis based on bioinformatics and machine learning
Song, H., Xinqi, M., Xu, W., Shiwei, Y., Lumin, C., Xiao, W., Liu, D., & Jun, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1118886 · Cited by 15
“found that bone resorption was increased in mice with IAPP deficiency, but the osteogenesis process was not significantly affected (45).”
BackgroundThe story of amylin: from physiology to therapy
Secher, A., Lutz, T. A., & Raun, K. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01465-4 · Cited by 16
“Although amylin’s role in bone metabolism has not been extensively explored, research indicates that amylin may influence bone remodelling processes, modulating the balance between bone resorption and formation 181,182 .”
Gut-Brain Endocrine Axes in Weight Regulation and Obesity Pharmacotherapy
Merlino, D. J., Blomain, E. S., Aing, A., & Waldman, S. A. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3030763 · Cited by 13
“amylin-deficient mice have generated inconclusive results, with some demonstrating an obese phenotype [147,148], while others have found no difference in food intake or weight [149–151].”
The role of amylin, a gut–brain axis hormone, in metabolic and neurological disorders
Muhammad, T., Pastore, S. F., Good, K., Yu, W. H., & Vincent, J. B. (2025) · FASEB BioAdvances · doi:10.1096/fba.2024-00151 · Cited by 14
“It has been reported that IAPP may affect bone formation and resorption, 68 and aberrant IAPP and adiponectin serum levels have been associated with bone metabolism disorders.”
Wookey, P. J., Zulli, A., Lo, C. Y., Hare, D. L., Schwarer, A. P., Darby, I. A., & Leung, A. Y. H. (2009) · Springer eBooks · doi:10.1007/978-90-481-2909-6_13 · Cited by 15
“The expression of CTR is thought an important factor in the control of the terminal differentiation of osteoclasts (derived from monocytes) and osteolysis (Hattersley and Chalmers 1989; Zaidi et al. 1993; Dacquin et al. 2004; Granholm et al. 2007, 2008).”
BackgroundAmylin(1–8) is Devoid of Anabolic Activity in Bone
Ellegaard, M., Thorkildsen, C., Petersen, S., Petersen, J. S., Jørgensen, N. R., Just, R., Schwarz, P., Ramírez, M. T., & Stahlhut, M. (2010) · Calcified Tissue International · doi:10.1007/s00223-010-9338-3 · Cited by 14
“partially reverse osteopenia in ovariectomized (OVX) rats [11, 13].”
BackgroundFood intake and meal pattern in IAPP knockout mice with and without infusion of exogenous IAPP
Olsson, M., Herrington, M. K., Reidelberger, R. D., Permert, J., Gebré‐Medhin, S., & Arnelo, U. (2012) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2011.638392 · Cited by 12
“This is consistent with the data from previous shorter studies showing that body weight in IAPP KO mice was not significantly different from WT body weight [24,26,31].”
ResultThe role of calcitonin receptor signalling in polyethylene particle-induced osteolysis
Neuerburg, C., Wedemeyer, C., Goedel, J., Schlepper, R., Hilken, G., Schwindenhammer, B., Schilling, A. F., Jäger, M., & Kauther, M. D. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2014.11.051 · Cited by 11
Role of Calcr expressing neurons in the medial amygdala in social contact among females
Fukumitsu, K., Huang, A. J. Y., McHugh, T. J., & Kuroda, K. O. (2023) · Molecular Brain · doi:10.1186/s13041-023-00993-4 · Cited by 12
“behavioral responses to social reunion Calcr gene knockout in mice produces embryonic lethality [13] and Calcrfl°x mice exhibit mildly altered social behaviors (data not shown), thus similar to our previous work we utilized an AAV-mediated short hairpin interference RNA (shRNA), namely AAV5-hH1-shCalcrCAG-EGFP, to kno…”
ResultWookey, P. J., Zulli, A., & Hare, D. L. (2009) · Histochemistry and Cell Biology · doi:10.1007/s00418-009-0600-6 · Cited by 12
“However, in studies using haploinsuYcient CTR mice, CTR has been implicated in bone formation ( Dacquin et al. 2004 ) although this interpretation is complicated because the genetic background of mice may be a contributing factor (Beamer et al. 1996; Davey et al. 2004).”
BackgroundMice Lacking the Calcitonin Receptor Do Not Display Improved Bone Healing
Appelt, J., Tsitsilonis, S., Otto, E., Jahn, D., Köhli, P., Baranowsky, A., Jiang, S., Fuchs, M., Bucher, C. H., Duda, G. N., et al. (2021) · Cells · doi:10.3390/cells10092304 · Cited by 12
“However, we and others [7,25,26] were able to show that the physiologic function of mammalian CT is the inhibition of bone formation, as CTR-deficient mice display high bone mass and enhanced osteoblast function.”
BackgroundThe bone-fat mass relationship: Laboratory studies
Cornish, J., Costa, J. L., & Naot, D. (2009) · IBMS BoneKEy · doi:10.1138/20090395 · Cited by 12
“Amylin-deficient mice have a typical osteoporotic phenotype, showing decreased bone density of long bones, low bone mass and a decrease in trabecular bone volume (35).”
BackgroundKang, I. S., & Kim, C. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-8023-5_6 · Cited by 10
McMullan, P., Maye, P. F., Yang, Q., Rowe, D. W., & Germain‐Lee, E. L. (2021) · JBMR Plus · doi:10.1002/jbm4.10570 · Cited by 10
“This interest has stemmed from the paradoxical phenotype that was observed in multiple reports showing that mice with global inactivation of Calcr display an elevated BV/TV and bone formation rate without any changes in total osteoblast or osteoclast number.((48,67)) Additional studies of the lineagespecific deletion…”
BackgroundParathyroid Hormone, Parathyroid Hormone-Related Protein, and Calcitonin
Holt, E. H., & Wysolmerski, J. J. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-381978-9.10041-1 · Cited by 11
Wookey, P. J. (2009) · The Open Zoology Journal · doi:10.2174/1874336600902010053 · Cited by 8
Hormones and Disorders of Mineral Metabolism
Bringhurst, F. R., Demay, M. B., & Kronenberg, H. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00028-9 · Cited by 16
Young, A. (2005) · Advances in pharmacology · doi:10.1016/s1054-3589(05)52016-7 · Cited by 8
Islet amyloid polypeptide does not suppress pancreatic cancer
Taylor, A. J., Panzhinskiy, E., Orban, P. C., Lynn, F. C., Schaeffer, D. F., Johnson, J. D., Kopp, J. L., & Verchere, C. B. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101667 · Cited by 7
Amylin Pharmacology in Alzheimer’s Disease Pathogenesis and Treatment
Casadesús, G., Corrigan, R. R., & Piontkivska, H. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666211201093147 · Cited by 7
“Importantly, the study of AMYR signaling in vivo is further complicated by the fact that no AMYR conformation is 100% specific to amylin binding [81, 82], and the fact that RAMPs are known to complex with nine different receptors, not just CalcR [100, 101].”
InfluentialShin, B., Hrdlicka, H. C., Delany, A. M., & Lee, S. (2021) · Endocrinology · doi:10.1210/endocr/bqab135 · Cited by 8
Fetal Control of Calcium and Phosphate Homeostasis – Lessons from Mouse Models
Kovács, C. S. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-387829-8.00014-7 · Cited by 7
Insight into Evolution and Conservation Patterns of B1-Subfamily Members of GPCR
Chakraborty, C., Sharma, A. R., Sharma, G., Bhattacharya, M., & Lee, S. (2020) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-020-10043-5 · Cited by 7
Westermark, G. T. (2005) · Wiley eBooks · doi:10.1002/9783527619344.ch28 · Cited by 7
Calcitonin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Hay, D. L., Poyner, D. R., & Walker, C. S. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f11/2019.4 · Cited by 6
Parathyroid Hormone, Parathyroid Hormone–Related Protein, and Calcitonin
Wysolmerski, J. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809965-0.00046-x · Cited by 6
Diabetes and Osteoporotic Fractures
Kemmis, K. L., & Stuber, D. (2005) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721705275409 · Cited by 6
Skeletal morphofunctional considerations and the pituitary-thyroid axis
considerations, S. M. (2009) · Frontiers in Bioscience-Scholar · doi:10.2741/s9 · Cited by 6
Activation of Calcitonin Receptor and Calcitonin Receptor-like Receptor by Membrane-anchored Ligands
Chang, C. L., Park, J., & Hsu, S. Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.020040 · Cited by 5
Disorders of Calcium, Phosphorus, and Bone Metabolism During Fetal and Neonatal Development
Kovács, C. S., & Ward, L. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814823-5.00045-3 · Cited by 7
Bhoj, E. J. K., Rajabi, F., Baker, S. W., Santani, A., & Tan, W. (2020) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2020.103903 · Cited by 5
Gedrange, T., Weingärtner, J., Hoffmann, A., Homuth, G., Ernst, F. D., Bokan, I., Mai, R., & Proff, P. (2008) · Advances in Medical Sciences · doi:10.2478/v10039-008-0005-0 · Cited by 4
“This group includes four genes encoding proteins described to be involved in ossification processes: Calcr encoding a calcitonin receptor [14], Mmp8 which encodes the matrix metallopeptidase 8 [15], Dmp1 encoding dentin matrix protein 1 [16], and Bglap2 encoding the bone gamma-carboxyglutamate protein 2 [17].”
BackgroundNaot, D., Musson, D. S., & Cornish, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00033-6 · Cited by 4
Physiological and Pathophysiological Role of Islet Amyloid Polypeptide (IAPP, Amylin)
Westermark, G. T. (2011) · Springer eBooks · doi:10.1007/978-1-4419-6956-9_15 · Cited by 4
“IAPP null mice have a 50% reduction in bone mass when compared to wild-type mice [110].”
BackgroundCalcitonin Gene Family of Peptides
Hu, M. I.-N., & Gagel, R. F. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00055-0 · Cited by 4
An update on diabetes related skeletal fragility
Abdalrahman, N., Chen, S. C., Wang, J. R., & Ahmed, S. F. (2015) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.984687 · Cited by 4
“Amylin-deficient mice displayed low bone mass with increased number of osteoclast [55] and that treatment with amylin in diabetic rat result in increased BMD and bone strength [54].”
BackgroundThe Role of Human IAPP in Stress and Inflammatory Processes in Type 2 Diabetes
Montané, J., & Novials, A. (2016) · InTech eBooks · doi:10.5772/63010 · Cited by 4
“Several other effects have been described, including the regulation of renal filtration [11], calcium homeostasis [12], and vasodilatation [13].”
BackgroundNowak, N., Czekanowska, D., Gębarowski, T., & Wiglusz, R. J. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213709 · Cited by 3
Grey, A. B. (2009) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-009-9047-5 · Cited by 4
“hormone that is co-secreted with insulin, and which restrains osteoclastogenesis and stimulates bone formation in vivo [20, 21 ].”
BackgroundThe Calcitonin Peptide Family: What Can We Learn from Receptor Knock Out and Transgenic Mice
Born, W., & Fischer, J. A. (2009) · Springer eBooks · doi:10.1007/978-90-481-2909-6_5 · Cited by 4
Bone and Rheumatic Disorders in Diabetes
Grey, A. B., & Dalbeth, N. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch48 · Cited by 2
Levasseur, R. (2019) · EMC - Aparato Locomotor · doi:10.1016/s1286-935x(19)42130-8 · Cited by 6
Self-citationEffects of Feeding on Bone Metabolism
Walsh, J., & Eastell, R. (2009) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-009-9052-8 · Cited by 2
Amylin and Calcitonin Gene-Related Peptide
Naot, D., Reid, I. R., & Cornish, J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00056-2 · Cited by 2
Findlay, D. M., Sexton, P. M., & Martin, T. J. (2016) · Endocrinology: Adult and Pediatric · doi:10.1016/b978-0-323-18907-1.00058-5 · Cited by 2
Levasseur, R. (2019) · EMC - Podología · doi:10.1016/s1762-827x(19)42712-0 · Cited by 1
Self-citationJiang, S., Xie, W., Ballhause, T. M., Sevecke, J., Augustin, R., Rolvien, T., Maleitzke, T., Baranowsky, A., & Keller, J. (2026) · Bone and Joint Research · doi:10.1302/2046-3758.152.bjr-2025-0025.r1 · Cited by 1
“- - - 11,45,46 CTR -defcient mice exhibited a high bone mass phenotype characterized by enhanced bone formation and unaltered bone resorption.”
Calcitonin receptors in GtoPdb v.2021.2
Hay, D. L., Poyner, D. R., & Walker, C. S. (2021) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f11/2021.2 · Cited by 1
Martin, T. J., Findlay, D. M., & Sexton, P. M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00057-5 · Cited by 2
Calcitonin receptors in GtoPdb v.2023.1
Garelja, M. L., Hay, D. L., Poyner, D. R., & Walker, C. S. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f11/2023.1 · Cited by 3
Bone and Rheumatic Disorders in Diabetes
Grey, A. B., & Dalbeth, N. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch59 · Cited by 1
Martin, T. J., & Sims, N. A. (2006) · Elsevier eBooks · doi:10.1016/b9-78-012088-5/62650-0169 · Cited by 2
(2004) · Neuropeptides · doi:10.1016/j.npep.2004.03.002 · Cited by 1
Bashar, M. A., Barua, L., Paul, S., Dash, N., Sadhu, T., Mitra, S., & Dash, R. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.16.623924 · Cited by 1
Non-neuronal roles for GDNF and novel GDNF family receptors
Lindahl, M. (2004) · Työväentutkimus Vuosikirja · Cited by 1
Cell and Molecular Biology of the Osteoclast and Bone Resorption
Duplan, M. B., Horne, W. C., & Baron, R. (2012) · Wiley eBooks · doi:10.1002/9781118704868.ch3
The calcitonin gene family of peptides : receptor expression and effects on bone cells
Granholm, S. (2008) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 1
Clinical and basic research papers - January and February selections
Seeman, E., & Strewler, G. J. (2004) · BoneKEy-Osteovision · doi:10.1138/20040127
Beckman, M. (2004) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2004.7.nf19
Experimental models for investigating IAPP regulation of food intake in rats and mice
Olsson, M. (2012) · Figshare
Historical Reflections and the Future
MacIntyre, I. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1402.079
Paulsson, J. F. (2006) · DiVA (Linkoping University)
Calcitonin: Its Physiological Role and Emerging Therapeutics
Cornish, J., Naot, D., & Martin, T. J. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2745-1_6 · Cited by 2
Extrapancreatic actions of incretin-based therapies on bone in diabetes mellitus
Mansur, S. A. (2015) · UTHM Institutional Repository (Universiti Tun Hussein Onn Malaysia)
GDNF FAMILY RECEPTORS IN PERIPHERAL TARGET INNERVATION AND HORMONE PRODUCTION
Lindfors, P. H. (2006) · Työväentutkimus Vuosikirja
CT, CGRP, Amylin, and Adrenomedullins
Hay, D. L., & Poyner, D. R. (2009) · CRC Press eBooks · doi:10.1201/9781420061161-c2
Reflections on Development of Concepts of Intercellular Communication in Bone
Martin, T. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00004-2 · Cited by 1
Fetal Control of Calcium and Phosphate Homeostasis
Kovács, C. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804182-6.00020-4
Role of receptor activity modifying protein-2 (RAMP2) in endocrine physiology of female mice
Kadmiel, M. (2011) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/5vta-n029
FEATURES OF MANAGEMENT IN PATIENTS WITH OSTEOPOROSIS AND DIABETES MELLITUS
Zhuravlyova, L., Oliinyk, M., & Sikalo, Y. K. (2021) · PROBLEMS OF ENDOCRINE PATHOLOGY · doi:10.21856/j-pep.2021.3.16
Martins, J. P. O. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/y9kj-2556
Bone and Rheumatic Disorders in Diabetes
Grey, A. B., & Dalbeth, N. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch53
Peptide Engineering Approach to Introduce an Improved Calcitonin Mutant
Zarei, M., Abedini, B., Dehshahri, A., & Negahdaripour, M. (2024) · Molecular Biology · doi:10.1134/s0026893324700110
Li, Q., Duan, Z., Sun, C., Zheng, J., Xu, G., & Yang, N. (2021) · Figshare · doi:10.6084/m9.figshare.16921625
Li, Q., Duan, Z., Sun, C., Zheng, J., Xu, G., & Yang, N. (2021) · Figshare · doi:10.6084/m9.figshare.16921631
Effects of Roux-en-Y gastric bypass surgery on energy expenditure and bone metabolism in rats
Abegg, K. (2014) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-104652
Fukumitsu, K., Huang, A. J. Y., McHugh, T. J., & Kuroda, K. O. (2023) · Figshare · doi:10.6084/m9.figshare.22598579
Fetal control of calcium and phosphate homeostasis
Ryan, B. A., & Kovács, C. S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13683-2.00007-4
Metadata
- Authors
- Dacquin, R., Davey, R. A., Laplace, C., Levasseur, R., Morris, H. A., Goldring, S. R., Gebre-Medhin, S., Galson, D. L., Zajac, J. D., & Karsenty, G.
- Affiliations
- Baylor College of Medicine (US)
- The University of Melbourne (AU)
- Beth Israel Deaconess Medical Center (US)
- 1Department of Molecular and Human Genetics and Bone Disease Program of Texas, Baylor College of Medicine, Houston, TX 77030
- Hanson Institute (AU)
- 5Department of Clinical Genetics, Lund University Hospital, SE-221 85, Lund, Sweden
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2004-02-16
- Volume
- 164
- Issue
- 4
- Pages
- 509-514
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC2171986
- OpenAlex
- W2108642017
- Semantic Scholar
- 435fe5512c7d1d24870030fa33708cac75f27d06
- Cited by
- 206
- References
- 25
- Citations by year
- 2026: 7 · 2025: 3 · 2024: 4 · 2023: 6 · 2022: 2 · 2021: 8 · 2020: 7 · 2019: 11 · 2018: 8 · 2017: 5 · 2016: 7 · 2015: 10 · 2014: 12 · 2013: 7 · 2012: 11
- FWCI
- 5.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Cell Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-sa)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058883, R01-DK58883)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01-AR45421, R01AR045421)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
- Keywords
- amylin, calcitonin receptor, bone resorption, bone formation, osteoclastogenesis, osteoclast precursors, ERK signaling, osteopenia, bone metabolism regulation
- MeSH terms
- Amyloid, Animals, Bone and Bones, Bone Resorption, Cell Differentiation, Mice, Inbred C57BL, Osteoclasts, Osteogenesis, Phenotype, Bone Density, Receptors, Calcitonin, Mice, Knockout, Mitogen-Activated Protein Kinases, Mice, Islet Amyloid Polypeptide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.